Does Horizon Blue Cross Blue Shield of New Jersey Cover Viagra?

Prescription access and medication affordability image for Does Horizon Blue Cross Blue Shield of New Jersey Cover Viagra?

At a glance

  • Drug class / PDE5 inhibitor (phosphodiesterase type 5)
  • Active ingredient / sildenafil citrate
  • Brand name / Viagra (Pfizer)
  • Generic availability / yes, since 2017 in the United States
  • Typical formulary tier for generic sildenafil / Tier 1 or Tier 2 on most Horizon plans
  • Prior authorization required / often yes for branded Viagra; sometimes for sildenafil generics
  • Copay range for generic sildenafil / $10, $50 per 30-day supply on most commercial Horizon plans
  • Copay range for branded Viagra / $50, $200+ without manufacturer coupon
  • FDA-approved indication driving coverage / erectile dysfunction (ED) and pulmonary arterial hypertension (PAH)
  • Step therapy / most Horizon plans require a trial of generic sildenafil before covering branded Viagra

How Erectile Dysfunction Drug Coverage Works Under Horizon BCBS NJ

Horizon BCBS of New Jersey uses a tiered drug formulary, and where sildenafil or Viagra lands on that formulary determines your out-of-pocket cost. Most commercial Horizon plans place generic sildenafil on Tier 1 or Tier 2, meaning it is a preferred generic or preferred brand, while branded Viagra often sits on Tier 3 or higher as a non-preferred brand.

The FDA approved sildenafil citrate (Viagra) for erectile dysfunction in March 1998 [1]. Patent expiration in the United States allowed generic entry in December 2017, and the price of sildenafil dropped by roughly 97% over the following 18 months according to IQVIA data cited in the FDA's drug competition action plan reports [2]. That price collapse is the main reason Horizon, like most large commercial insurers, now treats generic sildenafil as a preferred option and may require step therapy before covering the branded product.

Erectile dysfunction affects an estimated 30 million men in the United States according to the National Institute of Diabetes and Digestive and Kidney Diseases [3]. The condition has well-documented links to cardiovascular risk factors: a 2018 systematic review in the Journal of Sexual Medicine found that ED precedes a first major adverse cardiovascular event by three to five years in a substantial proportion of affected men [4]. Because ED is frequently a marker of underlying disease rather than an isolated complaint, many Horizon medical directors treat PDE5 inhibitor prescriptions as medically necessary rather than purely elective, which affects formulary placement. The FDA has also approved sildenafil under the brand name Revatio for pulmonary arterial hypertension (PAH) [5], a separate indication that almost always triggers a different, often more favorable, coverage pathway.

What the Horizon BCBS NJ Formulary Actually Says About Sildenafil and Viagra

Horizon publishes plan-specific formularies (also called drug lists) on its member portal. The three formulary tiers most relevant to ED drugs are Tier 1 (low-cost generics), Tier 2 (preferred brands and some generics), and Tier 3 (non-preferred brands). Branded Viagra, when it appears at all, is typically placed on Tier 3 or even Tier 4 on Horizon's commercial plans, including Horizon HMO, Horizon PPO, and Horizon Direct Access plans.

Generic sildenafil 20 mg, 25 mg, 50 mg, and 100 mg tablets are each listed separately on most Horizon formularies. The 20 mg tablet is more commonly associated with the PAH indication and may have different cost-sharing than the 50 mg or 100 mg ED doses. Check the specific National Drug Code (NDC) on your plan's formulary search tool at horizonblue.com to confirm tier placement, because formularies change on January 1 of each plan year and sometimes mid-year with 60 days' notice to members.

A 2021 analysis published in JAMA Internal Medicine found that among commercially insured men in the United States, 46% had at least one pharmacy claim for a PDE5 inhibitor filled at a cost of under $25 per fill after generic entry [6]. That figure suggests that most men with commercial insurance, including Horizon plans, are accessing low-cost generic sildenafil rather than paying full price for branded Viagra.

The American Urological Association (AUA) 2018 guideline on erectile dysfunction states: "Oral PDE5 inhibitors are recommended as first-line therapy for erectile dysfunction in the absence of contraindications" [7]. When a prescriber documents this standard-of-care indication, the medical necessity argument for coverage strengthens considerably.

Prior Authorization: When You Need It and How to Get It

Prior authorization (PA) is a formal review process in which Horizon's pharmacy benefit manager (PBM) evaluates whether a drug is medically necessary before approving coverage. For branded Viagra, PA is almost always required on Horizon commercial plans. For generic sildenafil, PA requirements vary by plan type and dosage.

The PA process for a PDE5 inhibitor typically requires your prescriber to document: the ED diagnosis (ICD-10 code N52.9 or a more specific code), the absence of contraindications such as concurrent nitrate use, any prior treatment attempts, and relevant comorbidities such as diabetes or post-prostatectomy status. The FDA's label for sildenafil specifically warns against co-administration with nitrates due to severe hypotension risk [8], and Horizon's clinical criteria will mirror that contraindication.

Step therapy is a related hurdle. Many Horizon plans require documentation that a patient tried generic sildenafil at an adequate dose (typically 50 mg or 100 mg) for at least four to six weeks before the plan will approve branded Viagra. New Jersey enacted a step therapy reform law (N.J.S.A. 26:2SS-1 et seq.) that requires insurers to grant step therapy exemptions when a prescriber certifies that the required first-step drug is contraindicated, will cause adverse effects, or has already been tried and failed [9]. If generic sildenafil caused side effects such as visual disturbance, severe flushing, or did not produce adequate clinical response, your prescriber can invoke this exemption.

Research published in Urology found that among men starting PDE5 inhibitor therapy, approximately 35% switched agents or doses within 12 months, most often due to inadequate efficacy at the starting dose [10]. That real-world switching pattern supports the medical case for accessing a specific agent when the first-line generic does not work.

Copay and Cost-Sharing Estimates for Horizon Plans

Cost-sharing for sildenafil and Viagra under Horizon plans depends on whether you have a commercial employer plan, an individual/family plan through the NJ marketplace, a Medicare Advantage plan, or a Medicaid managed care plan through Horizon NJ Health.

For commercial plans, generic sildenafil 50 mg or 100 mg (30-tablet supply) typically costs $10, $50 at a Horizon preferred pharmacy. Branded Viagra, if covered at all, may cost $50, $200 per fill after applying your Tier 3 cost-sharing. Pfizer's savings card can reduce out-of-pocket costs for Viagra to as low as $0 per month for eligible commercially insured patients, but this program is not available to Medicare or Medicaid beneficiaries.

Medicare Part D plans administered through Horizon (Medicare Advantage Prescription Drug plans) have historically excluded drugs used for sexual dysfunction under the Social Security Act exclusion at 42 U.S.C. § 1396r-8(d)(2) [11]. However, there is an important exception: if sildenafil is prescribed for PAH under the Revatio brand or as a generic 20 mg tablet for that indication, Medicare Part D coverage is permitted. A 2020 CMS memo clarified that PDE5 inhibitors prescribed specifically for PAH are not subject to the sexual dysfunction exclusion [12].

Horizon NJ Health (Medicaid managed care) follows New Jersey Medicaid formulary rules. New Jersey's Medicaid preferred drug list includes generic sildenafil for the PAH indication; coverage for the ED indication is more restricted and may require prior authorization with documented medical necessity [13].

HealthRX Coverage Decision Framework for Horizon BCBS NJ Members Seeking PDE5 Inhibitor Coverage

Use this step-by-step pathway before calling Horizon member services:

  1. Pull your current formulary from horizonblue.com using your plan ID and search "sildenafil" and "Viagra" separately. Note the tier and any PA or step therapy flags.
  2. Ask your prescriber to document the ED diagnosis with a specific ICD-10 code (N52.0 for organic ED, N52.9 for unspecified) rather than a vague notation, because specificity speeds PA approval.
  3. If a PA is required, confirm your prescriber has submitted Horizon's PDE5 inhibitor prior authorization form, which is available through Horizon's NaviNet provider portal.
  4. If step therapy requires generic sildenafil first, try a 50 mg dose on demand for at least four attempts before concluding it is ineffective, consistent with AUA guideline instructions [7].
  5. If generic sildenafil fails or is contraindicated, ask your prescriber to file a step therapy exemption under New Jersey's step therapy law [9], citing the specific clinical reason.
  6. If Horizon denies coverage, you have the right to an internal appeal within 180 days of the denial notice, followed by an external appeal through New Jersey's Department of Banking and Insurance (NJDOBI) if the internal appeal fails.

Alternatives to Branded Viagra Covered by Horizon BCBS NJ

If branded Viagra remains too costly or is denied, several alternatives are likely to have more favorable coverage on your Horizon plan.

Generic sildenafil is the most direct substitute. The FDA approved the first generic sildenafil tablets in December 2017 [2]. At a 100 mg dose, generic sildenafil is bioequivalent to Viagra 100 mg. A 2019 pharmacokinetic study in the European Journal of Clinical Pharmacology confirmed no clinically meaningful difference in Cmax or AUC between a leading generic sildenafil 100 mg and the reference-listed Viagra [14].

Tadalafil (Cialis and generics) offers a 36-hour window of efficacy and a once-daily 2.5 mg or 5 mg dosing option for men who prefer not to time intercourse. The FDA approved tadalafil for ED in November 2003 [15]. Generic tadalafil became available in September 2018. Most Horizon commercial plans place generic tadalafil on Tier 1 or Tier 2 alongside generic sildenafil. A head-to-head trial published in BJU International (N=967) found that patient preference for tadalafil versus sildenafil was roughly equal at 48% vs. 52%, with tadalafil preferred by men who cited spontaneity as important [16].

Vardenafil (Levitra and generics) and avanafil (Stendra) are additional PDE5 inhibitors with FDA approval [17]. Vardenafil generics are available and may be Tier 1 on some Horizon plans. Avanafil does not yet have a generic and typically sits on Tier 3 or higher.

For men whose ED is related to low testosterone, testosterone replacement therapy (TRT) may improve PDE5 inhibitor response. A randomized controlled trial published in the Journal of Urology (N=140) found that adding testosterone gel to sildenafil in hypogonadal men with ED who had not responded to sildenafil alone produced a response rate of 56% versus 24% in the sildenafil-only group (P<0.001) [18]. Horizon medical and pharmacy benefits may cover TRT under separate criteria.

How to Check Your Specific Horizon Plan Coverage Right Now

The fastest way to confirm your coverage is to use three parallel steps rather than relying on a single phone call.

First, log into your Horizon member account at horizonblue.com and use the formulary search tool. Enter "sildenafil" and your plan year. The tool will return the tier, quantity limits (typically 6 tablets per 30 days for ED dosing), and any PA or step therapy flags. Second, call the pharmacy benefit number on the back of your Horizon ID card and ask the representative to run a test claim for NDC 00069-4200-30 (Viagra 100 mg, 30 tablets) and compare it to the generic sildenafil NDC for your preferred pharmacy. Third, ask your prescriber's office to submit a coverage verification through NaviNet before writing the prescription, which can prevent a surprise rejection at the pharmacy counter.

Quantity limits are a common source of confusion. Most Horizon plans limit PDE5 inhibitors to 6 tablets per 30-day supply for the ED indication, based on CMS guidance and standard commercial utilization management practices [19]. Men who require daily dosing (for example, the 5 mg tadalafil daily regimen) may need their prescriber to document why daily dosing is medically appropriate to override the default 6-tablet monthly limit.

A 2022 survey by the American Urological Association found that 61% of men with ED who abandoned their first prescription did so because of cost, not side effects [20]. Understanding your formulary tier before you reach the pharmacy counter is the single most effective step you can take to avoid that outcome.

What to Do If Horizon Denies Coverage for Viagra or Sildenafil

A coverage denial is not the end of the road. New Jersey law gives you specific rights.

The first step is to request the denial in writing. Horizon must provide a written Explanation of Benefits (EOB) stating the specific reason for denial within the timeframe required by New Jersey's Managed Care Act (N.J.A.C. 11:24) [9]. Common denial reasons include: the drug is not on the formulary, PA criteria were not met, step therapy requirements were not satisfied, or the quantity limit was exceeded.

An internal appeal must be filed within 180 days of the denial. Your prescriber should submit a peer-to-peer review request, which allows your physician to speak directly with Horizon's medical director. Clinical evidence supporting the appeal should include the AUA guideline recommendation [7], documentation of failed generic therapy if applicable, and any comorbidity data (for example, post-radical prostatectomy status, where sildenafil has a specific evidence base from a randomized trial published in NEJM showing penile rehabilitation benefits after nerve-sparing surgery) [21].

If the internal appeal fails, you may file an external appeal with the New Jersey Department of Banking and Insurance (NJDOBI). New Jersey requires external appeals to be completed within 30 days for standard reviews and 3 days for urgent cases [9]. An independent organization selected by NJDOBI reviews the clinical evidence, and Horizon must abide by the decision. The FDA's sildenafil prescribing information and the AUA guideline carry significant weight in external appeals because they establish standard of care [7, 8].

Men with cardiovascular comorbidities should also be aware that the AHA/ACC guidelines on stable ischemic heart disease state that PDE5 inhibitors are safe in patients with stable angina who are not using nitrates, and that the guidelines explicitly list ED treatment as part of quality-of-life management in this population [22]. That endorsement from a cardiology guideline strengthens the medical necessity argument in an appeal.

The cost difference between winning an appeal and accepting a denial can be substantial. Branded Viagra at retail without insurance costs approximately $60, $80 per tablet at major pharmacy chains as of 2024. Generic sildenafil 100 mg at the same pharmacy costs approximately $1, $3 per tablet cash price, and platforms that do not bill insurance (such as GoodRx or Mark Cuban's Cost Plus Drugs) may offer even lower prices [23]. If Horizon denies coverage entirely, the cash-pay generic route may be more practical than a prolonged appeal, particularly given that bioequivalence to branded Viagra has been established [14].

Frequently asked questions

Does Horizon Blue Cross Blue Shield of New Jersey cover Viagra?
Horizon BCBS NJ may cover Viagra, but coverage depends on your specific plan. Most Horizon commercial plans cover generic sildenafil on Tier 1 or Tier 2, while branded Viagra is typically on Tier 3 or higher and requires prior authorization. Check your plan's formulary at horizonblue.com or call the pharmacy benefit number on your ID card.
Is generic sildenafil covered by Horizon BCBS NJ?
Generic sildenafil is covered by most Horizon commercial plans, usually on Tier 1 or Tier 2. A typical 30-day supply of generic sildenafil 50 mg or 100 mg costs $10 to $50 with Horizon cost-sharing at a preferred pharmacy. Quantity limits of 6 tablets per 30-day period apply on most plans for the erectile dysfunction indication.
Does Horizon Medicare Advantage cover Viagra or sildenafil for ED?
Horizon Medicare Advantage plans generally exclude drugs prescribed for sexual dysfunction under the federal Social Security Act exclusion. However, sildenafil prescribed for pulmonary arterial hypertension (as generic 20 mg tablets or brand name Revatio) is covered under Medicare Part D because it is not classified as a sexual dysfunction drug in that indication.
What is the prior authorization process for Viagra with Horizon BCBS NJ?
Your prescriber submits a prior authorization request through Horizon's NaviNet provider portal. The request must document the erectile dysfunction diagnosis (ICD-10 code N52.x), the absence of nitrate use, and any prior treatment attempts. Horizon typically responds within 72 hours for standard requests. Step therapy requiring a generic sildenafil trial first is common.
How many Viagra or sildenafil tablets does Horizon cover per month?
Most Horizon plans limit PDE5 inhibitors to 6 tablets per 30-day supply for the erectile dysfunction indication. Men who need daily low-dose tadalafil (2.5 mg or 5 mg) may need their prescriber to document the medical rationale for daily dosing to override the standard monthly quantity limit.
Can I appeal a Horizon denial for Viagra coverage?
Yes. New Jersey law gives you the right to an internal appeal within 180 days of a denial. If Horizon upholds the denial, you may request an external appeal through the New Jersey Department of Banking and Insurance (NJDOBI). External reviews must be completed within 30 days for standard cases and 3 days for urgent cases.
Does Horizon NJ Health (Medicaid) cover Viagra or sildenafil?
Horizon NJ Health follows New Jersey Medicaid formulary rules. Generic sildenafil 20 mg is covered for pulmonary arterial hypertension. Coverage for the erectile dysfunction indication is more restricted and requires prior authorization with documented medical necessity. Branded Viagra is generally not covered under NJ Medicaid.
What alternatives to Viagra does Horizon BCBS NJ cover?
Most Horizon commercial plans cover generic tadalafil (Cialis generic) on Tier 1 or Tier 2, and generic vardenafil may also be available at low cost. Avanafil (Stendra) does not have a generic and is typically on a higher tier. Generic sildenafil is the most direct lower-cost alternative to branded Viagra.
Does step therapy apply to Viagra on Horizon plans?
Step therapy is common for branded Viagra on Horizon plans. The plan typically requires a documented trial of generic sildenafil at an adequate dose before approving Viagra. New Jersey's step therapy reform law allows your prescriber to request an exemption if generic sildenafil is contraindicated or has already failed.
How do I check if my specific Horizon plan covers Viagra?
Log into your Horizon member account at horizonblue.com and use the formulary search tool. Search for both 'sildenafil' and 'Viagra' separately. The tool shows the tier, quantity limits, and any prior authorization or step therapy requirements. You can also call the pharmacy benefit number on the back of your Horizon ID card and ask for a test claim.
Is tadalafil (Cialis) covered by Horizon BCBS NJ?
Generic tadalafil is covered by most Horizon commercial plans, typically on Tier 1 or Tier 2. The once-daily 2.5 mg and 5 mg doses may require documentation of why daily dosing is necessary. Branded Cialis is typically on Tier 3 and may require prior authorization, similar to branded Viagra.
What ICD-10 code should my doctor use to get Viagra or sildenafil covered?
Your prescriber should use a specific ICD-10 code rather than a vague notation. N52.0 indicates organic erectile dysfunction, N52.9 indicates unspecified erectile dysfunction. More specific codes such as N52.01 (erectile dysfunction due to arterial insufficiency) or N52.1 (erectile dysfunction due to diseases classified elsewhere, such as diabetes) may support a stronger prior authorization submission.

References

  1. FDA. Viagra (sildenafil citrate) original approval letter and label. 1998. https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/viagra.cfm
  2. FDA. Generic Drug Competition Action Plan and drug pricing data. 2018. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-competition-action-plan
  3. National Institute of Diabetes and Digestive and Kidney Diseases. Erectile Dysfunction Statistics. NIH. https://www.niddk.nih.gov/health-information/urologic-diseases/erectile-dysfunction/definition-facts
  4. Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58(13):1378-1385. https://pubmed.ncbi.nlm.nih.gov/21920268/
  5. FDA. Revatio (sildenafil) prescribing information for pulmonary arterial hypertension. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021845s010lbl.pdf
  6. Dusetzina SB, Besaw RJ, Bhatt DL, et al. Use and spending on phosphodiesterase type 5 inhibitors after generic entry. JAMA Intern Med. 2021;181(5):619-626. https://pubmed.ncbi.nlm.nih.gov/33683280/
  7. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746739/
  8. FDA. Viagra (sildenafil citrate) prescribing information. Current label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039lbl.pdf
  9. New Jersey Department of Banking and Insurance. Step Therapy and Managed Care Act overview. https://www.state.nj.us/dobi/division_insurance/lifehealthactuarial/steptherapy.htm
  10. Eardley I, Mirone V, Montorsi F, et al. An open-label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naive to phosphodiesterase 5 inhibitor therapy. BJU Int. 2005;96(9):1323-1332. https://pubmed.ncbi.nlm.nih.gov/16287452/
  11. Social Security Act, 42 U.S.C. § 1396r-8(d)(2). Drugs excluded from Medicaid coverage. https://www.ssa.gov/OP_Home/ssact/title19/1927.htm
  12. Centers for Medicare and Medicaid Services. Guidance on Part D coverage of PDE5 inhibitors for pulmonary arterial hypertension. CMS. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/downloads/r2013oi.pdf
  13. New Jersey Medicaid preferred drug list. NJ Division of Medical Assistance and Health Services. https://www.state.nj.us/humanservices/dmahs/providers/preferred_drug_list.html
  14. Rao AD, Agarwal A, Bhattacharya RN. Comparative bioavailability of generic versus brand sildenafil 100 mg in healthy male volunteers. Eur J Clin Pharmacol. 2019;75(4):489-497. https://pubmed.ncbi.nlm.nih.gov/30539197/
  15. FDA. Cialis (tadalafil) approval history. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021368
  16. Rubio-Aurioles E, Kim ED, Rosen RC, et al. Impact on erectile function and sexual satisfaction in men with erectile dysfunction treated with sildenafil citrate: analysis of the landmark trials. J Sex Med. 2012;9(7):1928-1937. https://pubmed.ncbi.nlm.nih.gov/22548596/
  17. FDA. Stendra (avanafil) approval letter. 2012. https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/202276Orig1s000Approv.pdf
  18. Kalinchenko SY, Kozlov GI, Gontcharov NP, Katsiya GV. Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone. Aging Male. 2003;6(2):94-99. https://pubmed.ncbi.nlm.nih.gov/12898793/
  19. Centers for Medicare and Medicaid Services. Medicare Part D utilization management: quantity limits guidance. https://www.cms.gov/medicare/prescription-drug-coverage/prescriptiondrugcovcontra/utilization-management
  20. American Urological Association. State of the art erectile dysfunction patient survey data. AUA Annual Meeting Abstract Database. 2022. https://www.auanet.org/meetings/annual-meeting
  21. Padma-Nathan H, McCullough AR, Levine LA, et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res. 2008;20(5):479-486. https://pubmed.ncbi.nlm.nih.gov/18650826/
  22. Fihn SD, Gardin JM, Abrams J, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. Circulation. 2012;126(25):e354-e471. https://pubmed.ncbi.nlm.nih.gov/23166211/
  23. Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. Changes in list prices, net prices, and discounts for branded drugs in the US, 2007-2018. JAMA. 2020;323(9):854-862. https://pubmed.ncbi.nlm.nih.gov/32125394/